<!DOCTYPE html>

<html lang="fa">
<meta content="text/html;charset=utf-8" http-equiv="content-type"/>
<head><title>Hypercoagulability</title><link href="/d/css/bootstrap.min.css" rel="stylesheet"/><link href="/d/css/icofont.min.css" rel="stylesheet"/><link href="/d/css/classy-nav.min.css" rel="stylesheet"/><link href="/d/css/animate.css" rel="stylesheet"/><link href="/d/css/owl.carousel.css" rel="stylesheet"/><link href="/d/css/magnific-popup.css" rel="stylesheet"/><link href="/d/css/owl.theme.default.min.css" rel="stylesheet"/><link href="/d/css/style.css" rel="stylesheet"/><link href="/d/css/rtl_edited.css" rel="stylesheet"/><link href="/d/css/responsive.css" rel="stylesheet"/><link href="https://medilib.ir/uptodate_assets/main.css" rel="stylesheet">
<style>

#myUL {
  list-style-type: none;
  padding: 0;
  margin: 0;
}

#myUL li a {
  border: 1px solid #ddd;
  margin-top: -1px; /* Prevent double borders */
  background-color: #f6f6f6;
  padding: 12px;
  text-decoration: none;
  font-size: 16px;
  color: black;
  display: block
}

#myUL li a:hover:not(.header) {
  background-color: #eee;
}

#searchResult {

  list-style-type: none;
  padding: 0;
  padding-right: 20px;
}

#searchResult li a {
  border: .5px solid #ddd;
  margin-top: -1px; /* Prevent double borders */
  background-color: #79bc21;
  padding: 7px;
  text-decoration: none;
  font-size: 14px;
  color: white;
  display: block
}

#searchResult li a:hover:not(.header) {
  background-color: #222;
}


#txtHint   {
  position: absolute;
  text-shadow: none;
  width: 100%;
  margin-top: -15px;
  padding-right: 10px;

  filter: alpha(opacity=95);
  -moz-opacity: 0.95;
  opacity: 1;
  z-index: 200;
}
.countBubl {
  background:#eb0029;
  color:#fff;
  padding:5px;
  margin-top: 50%;

}
.uptodate-area > div:nth-child(1) > div:nth-child(1) > div:nth-child(1) > span:nth-child(1) > img:nth-child(2) {
 width: 55%;
 padding-left: 20px;
}
.uptodate-area > div:nth-child(1) > div:nth-child(1) > div:nth-child(1) > span:nth-child(1) > img:nth-child(3) {
 width: 20%;
}
 #Uptodate_image {
      width: 50%;
  }#uptodate-area {
      /*z-index: 99;*/
  }
#uptodate-area > div:nth-child(1) > div:nth-child(1) > div:nth-child(1) > div:nth-child(2) {
 margin-left: 10px;
 margin-bottom: 6%;
}
@media (max-width: @screen-xs) {
    .countBubl {
        font-size: 4px ;
    }
    #uptodate_version {
        font-size: 4px ;
    }
}

@media (max-width: @screen-sm) {
    .countBubl {
        font-size: 14px ;
    }
}
@media  all and(max-width: 820) {
    #Uptodate_image {
        width: 80% ;
    }#uptodate-area {
        z-index: 99;
    }
}@media  all and (min-width: 820) and(max-width: 88820){
    #Uptodate_image {
        width: 100% !important;
    }
    .countBubl {
        font-size: 4px ;
    }
}
div.col-md-3:nth-child(3) {
 margin-top: 6%;
}

div.col-md-3:nth-child(3) > img:nth-child(1) {
 width: 100%;
 margin-left: 11px;
}

</style>
<style media="screen" type="text/css">
  .goback {
    width: 200px;
    height: 40px;
    line-height: 40px;
    position: fixed;
    display: none;
    font-size: 15px;
    background: #71c0fa;
    z-index: 1000;
    text-align: center;
    color: #ffffff;
    -webkit-border-radius: 1px;
    -moz-border-radius: 1px;
    border-radius: 50px;
    bottom: 3.8%;
    right: 2%;
}
  .buyPackage {
  width: 100px;
  height: 100px;
  line-height: 40px;
  position: fixed;
  display: none;
  font-size: 10px;
  background: #fa759e;
  z-index: 1000;
  text-align: center;
  color: #ffffff;
  -webkit-border-radius: 1px;
  -moz-border-radius: 1px;
  border-radius: 10px;
  top: 150px;
  right: 2%;
  text-align: center;
}
.uptodate-area {
  /*background-image: url(../../assets/img/news-letter-bg.jpg);*/
  background-position: center center;
  background-size: cover;
  background-repeat: no-repeat;
    background-attachment: fixed;
  position: relative;
}
.uptodate-area::before {
  content: '';
  position: absolute;
  left: 0;
  padding-top: 100px;
  width: 100%;
}
#references{
  display: none;
}
</style>
<style>
section.sticky {
  position: sticky;
  top: 0;
  background-color: #fff !important;
  /*z-index: 100;*/
  /*padding-top: 80px;*/

}
.m4inb{
    border: solid !important;
  }

  .newsletter-area::before {
       background: unset !important;
  }
p {
    color: #555;
}
</style>

<meta content="" name="description"/>
<link href="/d/img/favicon.png" rel="icon" type="image/png"/>
</link></head>
<body>
<!-- Start Main Menu Area -->

<br/>
<br/>
<br/>
<br/>
<div class="container">
<div class="row">
</div>
</div>




<section class="teacher-area ptb-10">
<div class="container">
</div>

<section class="course-details-area ptb-60">
<div class="container">
<div class="uptodate2" style="padding:50px 0px 50px 0px;direction: ltr;text-align: left;">
<h1 style="text-align:center">Hypercoagulability</h1>
<div class="graphic"><div class="figure"><div class="ttl">Hypercoagulability</div><div class="cntnt"><img src="data:jpeg;base64,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"/></div><div class="graphic_lgnd">Citrated rapid thromboelastography study (rapid-TEG) reflecting hypercoagulability. The red tracing indicates a normal study.<br/>This study shows a shortened to normal ACT, R time, and K time, reflecting enzymatic hypercoagulability; high alpha angle, MA, and G, reflecting platelet hypercoagulability and/or excessive fibrin deposition; and normal LY30. To distinguish the relative contribution of platelet hypercoagulability and excessive fibrin deposition, one would need to perform TEG platelet mapping or rotation thromboelastometry (RoTEM) fibrin function testing.</div><div class="graphic_footnotes">R (reaction time): time from sample placement or activation until the tracing amplitude reaches 2 mm; K (clot formation time): time elapsed between the R-time and the point where the tracing amplitude reaches 20 mm; alpha angle: angle between the middle line of the tracing and a tangential line to the developing "body" of the tracing; MA (maximal amplitude): the maximal amplitude reached after clot initiation; G: a calculated measure of total clot strength based on amplitude; LY30: the amount of clot lysis detected 30 minutes after the maximal amplitute (MA) is reached; SP (split point): time from sample placement (or activation with an exogenous procoagulant) until the earliest detectable resistance.</div><div id="graphicVersion">Graphic 58977 Version 4.0</div></div></div>
</div>
</div>

</section>

</section>
<!-- End Main Menu Area -->
<!-- Start Search Popup Area -->


<!-- End Footer Area -->
<!-- Back to top -->

<a class="scrolltop" href="#top"><i class="icofont-hand-drawn-up"></i></a>
<!-- End Back to top -->
<!-- jQuery Min JS -->

<!-- Prpper JS -->

<!-- Bootstrap Min JS -->

<!-- Classy Nav Min Js -->

<!-- Owl Carousel Min Js -->

<!-- Magnific Popup JS -->

<!-- CounterUp JS -->

<!-- Waypoints JS -->

<!-- Form Validator Min JS -->

<!-- Contact Form Min JS -->

<!-- Main JS -->

<!-- Global site tag (gtag.js) - Google Analytics -->






</body>
</html>
